scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023236017 |
P356 | DOI | 10.1023/A:1005686114356 |
P698 | PubMed publication ID | 11032336 |
P2093 | author name string | Berger J | |
Molzer B | |||
Rauschka H | |||
Forss-Petter S | |||
Hobel A | |||
Netik A | |||
P2860 | cites work | Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy | Q22009167 |
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters | Q24321939 | ||
Altered expression of ALDP in X-linked adrenoleukodystrophy | Q24671055 | ||
A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice | Q32159154 | ||
Cotransfection of granulosa cells with simian virus 40 and Ha-RAS oncogene generates stable lines capable of induced steroidogenesis | Q33654966 | ||
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis | Q34720182 | ||
The second-messenger dysbalance hypothesis of affective disorders | Q37907864 | ||
Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. | Q38331491 | ||
Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression | Q40968806 | ||
Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. | Q41288437 | ||
Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine | Q41865847 | ||
Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia | Q42461446 | ||
Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy | Q42542201 | ||
The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis. | Q47687463 | ||
Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP. | Q48017390 | ||
Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. | Q54206301 | ||
In-patient major depression: is rolipram as effective as amitriptyline? | Q54683459 | ||
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder | Q67977523 | ||
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation | Q72113162 | ||
Lovastatin for X-linked adrenoleukodystrophy | Q77207441 | ||
Regulation of IL-15-stimulated TNF-alpha production by rolipram | Q78145280 | ||
P433 | issue | 6 | |
P921 | main subject | fatty acid | Q61476 |
P304 | page(s) | 615-624 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | Journal of Inherited Metabolic Disease | Q6295359 |
P1476 | title | Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice | |
P478 | volume | 23 |
Q36622676 | The peroxisomal ABC transporter family | cites work | P2860 |
Search more.